Pilot Investigation of a Multinutrient Supplement on Skin Aging and Aging Metabolites in Healthy Women

N/ACompletedNCT00541931

Stanford University37 enrolled

Overview

We are seeking healthy female volunteers to determine if multinutrient supplementation affects visible signs of skin aging as well as blood measurements of aging. We are seeking smokers and non-smokers.

Skin antioxidant levels as well as blood metabolites may change as the human body ages1,2. Although the chronological aging process is unstoppable, the physical signs of aging, particularly characteristics of the skin, may be delayed through a variety of medical interventions such as topical medications or resurfacing lasers. It is not currently known whether skin carotenoid antioxidant levels correlate with skin aging characteristics, although studies with other antioxidants suggest this may be true 3. In addition, while selected blood metabolites correlate with changes in age2, we do not know if this correlates with skin changes. Our current study focuses on whether differences in skin carotenoid levels and blood metabolite levels correlate with skin aging characteristics in age-matched subjects. Furthermore, we will explore whether three months consumption with a commercial multi-nutrient formulation (LifePak Nano) affects metabolic markers of aging, skin aging characteristics including skin elasticity and transepidermal water loss. We will also examine whether smokers respond differently from nonsmokers in the above parameters after supplementation.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Skin Diseases

Interventions

Dietary Supplement: LifePak NanoDRUG

Daily use

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria:- Fitzpatrick Skin type I or II * Nonpregnant Females, age 18-30 or 50-70 * Body Mass Index Normal or Overweight * If age 18-30, must be non-smoker * Willing to fast for 8 hours prior to a blood draw; Exclusion Criteria:- History of cosmetic surgery * Use of anti-aging medications within 3 months of enrollment * Use of over-the-counter anti-aging creams (not sunscreens) more than once per week within one month of enrollment * Use of dietary supplements including vitamins within one month of enrollment * Use of tanning beds or excessive UV exposure (greater than 2 hours per day) within one month of enrollment * Use of sunless tanners within one month of enrollment * Uncontrolled or ongoing serious medical condition * Participation in another clinical study involving use of an investigational drug or product * Medical condition which, at the discretion of the investigator, will have a significant impact on ability to judge participant's skin characteristics, including age.

Locations (1)

Stanford University School of Medicine

Stanford, California, United States

Outcomes

Primary Outcomes

Fold Change in Long Chain Fatty Acids

Peripheral blood long chain fatty acids were measured. Fold change of 1 = no difference; if metabolites decrease at week 12 from baseline, the fold change will be \<1.

Time frame: Baseline; Week 12

Change in Fine Wrinkling

Assessed by 4 dermatologists blinded to chronological age and smoking status, on a 10-point Likert scale (min 1/max 10); lower scores indicate less wrinkling and higher scores indicate more wrinkling. Values are the average of scores given by the four raters. Change was calculated as the baseline value minus the week 12 value.

Time frame: Baseline; week 12

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.